Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-10-23-Speech-2-464-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-10-23"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"en"^^xsd:language2
lpv:document identification number	"en.20121023.45.2-464-000"2
lpv:hasSubsequent	lp_eu:2012-10-23-Speech-2-464-5002
lpv:speaker	lp:David Martin2
lpv:spoken text	"I welcome this report which acknowledges the European Medicines Agency’s efforts to address the discharge authority’s concerns with regard to the prevention and management of conflict of interest; and notes in particular the reports of 29 June 2012 and 7 August 2012 received by the discharge authority on the review of the conflict of interest management cases identified by the IAS and on the review of potential conflicts of interest of experts involved in assessing the medicinal product Pandemrix."@en1
lpv:spokenAs	member; Delegation for relations with the Korean Peninsula (2009-09-17--2014-06-30)3 member; INTA (2012-01-19--2014-06-30)3 member; AFCO (2012-01-19--2014-06-30)3 member; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-16--2014-06-30)3 chair; Delegation to the Cariforum — EU Parliamentary Committee (2010-09-08--2014-06-30)3 unknown; Labour Party (2009-07-14--2014-06-30)3 member; S&D (2009-07-14--2014-06-30)3 member; DROI (2012-01-19--2014-06-30)3 member; Conference of Delegation Chairs (2010-09-08--2014-06-30)3
lpv:unclassifiedMetadata	"David Martin (S&D ),"1 "in writing."1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph